BACKGROUND: Myosin IIA is an essential platelet contractile protein that is regulated by phosphorylation of its regulatory light chain (MLC) on residues (Thr)18 and (Ser)19 via the myosin light chain kinase (MLCK). OBJECTIVE: The present study was carried out to elucidate the mechanisms regulating MLC (Ser)19 and (Thr)18 phosphorylation and the functional consequence of each phosphorylation event in platelets. RESULTS: Induction of 2MeSADP-induced shape change occurs within 5s along with robust phosphorylation of MLC (Ser)19 with minimal phosphorylation of MLC (Thr)18. Selective activation of G(12/13) produces both slow shape change and comparably slow MLC (Thr)18 and (Ser)19 phosphorylation. Stimulation with agonists that trigger ATP secretion caused rapid MLC (Ser)19 phosphorylation while MLC (Thr)18 phosphorylation was coincident with secretion. Platelets treated with p160(ROCK) inhibitor Y-27632 exhibited a partial inhibition in secretion and had a substantial inhibition in MLC (Thr)18 phosphorylation without effecting MLC (Ser)19 phosphorylation. These data suggest that phosphorylation of MLC (Ser)19 is downstream of Gq/Ca(2+) -dependent mechanisms and sufficient for shape change, whereas MLC (Thr)18 phosphorylation is substantially downstream of G(12/13) -regulated Rho kinase pathways and necessary, probably in concert with MLC (Ser)19 phosphorylation, for full contractile activity leading to dense granule secretion. Overall, we suggest that the amplitude of the platelet contractile response is differentially regulated by a least two different signaling pathways, which lead to different phosphorylation patterns of the myosin light chain, and this mechanism results in a graded response rather than a simple on/off switch.
BACKGROUND:Myosin IIA is an essential platelet contractile protein that is regulated by phosphorylation of its regulatory light chain (MLC) on residues (Thr)18 and (Ser)19 via the myosin light chain kinase (MLCK). OBJECTIVE: The present study was carried out to elucidate the mechanisms regulating MLC (Ser)19 and (Thr)18 phosphorylation and the functional consequence of each phosphorylation event in platelets. RESULTS: Induction of 2MeSADP-induced shape change occurs within 5s along with robust phosphorylation of MLC (Ser)19 with minimal phosphorylation of MLC (Thr)18. Selective activation of G(12/13) produces both slow shape change and comparably slow MLC (Thr)18 and (Ser)19 phosphorylation. Stimulation with agonists that trigger ATP secretion caused rapid MLC (Ser)19 phosphorylation while MLC (Thr)18 phosphorylation was coincident with secretion. Platelets treated with p160(ROCK) inhibitor Y-27632 exhibited a partial inhibition in secretion and had a substantial inhibition in MLC (Thr)18 phosphorylation without effecting MLC (Ser)19 phosphorylation. These data suggest that phosphorylation of MLC (Ser)19 is downstream of Gq/Ca(2+) -dependent mechanisms and sufficient for shape change, whereas MLC (Thr)18 phosphorylation is substantially downstream of G(12/13) -regulated Rho kinase pathways and necessary, probably in concert with MLC (Ser)19 phosphorylation, for full contractile activity leading to dense granule secretion. Overall, we suggest that the amplitude of the platelet contractile response is differentially regulated by a least two different signaling pathways, which lead to different phosphorylation patterns of the myosin light chain, and this mechanism results in a graded response rather than a simple on/off switch.
Authors: J Polgár; J M Clemetson; B E Kehrel; M Wiedemann; E M Magnenat; T N Wells; K J Clemetson Journal: J Biol Chem Date: 1997-05-23 Impact factor: 5.157
Authors: Y Suzuki; M Yamamoto; H Wada; M Ito; T Nakano; Y Sasaki; S Narumiya; H Shiku; M Nishikawa Journal: Blood Date: 1999-05-15 Impact factor: 22.113
Authors: M Uehata; T Ishizaki; H Satoh; T Ono; T Kawahara; T Morishita; H Tamakawa; K Yamagami; J Inui; M Maekawa; S Narumiya Journal: Nature Date: 1997-10-30 Impact factor: 49.962
Authors: Prajeeda M Nair; Shaunak G Pandya; Shatha F Dallo; Kristin M Reddoch; Robbie K Montgomery; Heather F Pidcoke; Andrew P Cap; Anand K Ramasubramanian Journal: Br J Haematol Date: 2017-06-04 Impact factor: 6.998
Authors: Lurong Lian; Aae Suzuki; Vincent Hayes; Sougata Saha; Xuemei Han; Tao Xu; John R Yates; Mortimer Poncz; Anna Kashina; Charles S Abrams Journal: Haematologica Date: 2013-11-29 Impact factor: 9.941
Authors: David G Menter; Stephanie C Tucker; Scott Kopetz; Anil K Sood; John D Crissman; Kenneth V Honn Journal: Cancer Metastasis Rev Date: 2014-03 Impact factor: 9.264
Authors: Swapan K Dasgupta; Anhquyen Le; Sandra B Haudek; Mark L Entman; Rolando E Rumbaut; Perumal Thiagarajan Journal: PLoS One Date: 2013-12-16 Impact factor: 3.240
Authors: Aae Suzuki; Jae-Won Shin; Yuhuan Wang; Sang H Min; Morty Poncz; John K Choi; Dennis E Discher; Chris L Carpenter; Lurong Lian; Liang Zhao; Yangfeng Wang; Charles S Abrams Journal: PLoS One Date: 2013-07-23 Impact factor: 3.240